发明授权
US07897175B2 Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
有权
包含CETP抑制剂和HMG-CoA还原酶抑制剂的剂型
- 专利标题： Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
- 专利标题（中）： 包含CETP抑制剂和HMG-CoA还原酶抑制剂的剂型
-
申请号： US10739567申请日： 2003-12-18
-
公开(公告)号： US07897175B2公开(公告)日： 2011-03-01
- 发明人: Dwayne T. Friesen , David K. Lyon , Douglas A. Lorenz , Bruno C. Hancock , Timothy J. McDermott , Ravi M. Shanker
- 申请人： Dwayne T. Friesen , David K. Lyon , Douglas A. Lorenz , Bruno C. Hancock , Timothy J. McDermott , Ravi M. Shanker
- 申请人地址： US OR Bend
- 专利权人： Bend Research, Inc.
- 当前专利权人： Bend Research, Inc.
- 当前专利权人地址： US OR Bend
- 代理机构： Chernoff, Vilhauer, McClung & Stenzel
- 主分类号： A61K9/14
- IPC分类号： A61K9/14 ; A61K9/20 ; A61K9/48
摘要：
A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
公开/授权文献
信息查询
